The adjunctive use of intraoperative molecular imaging (IMI) is gaining acceptance as a potential means to improve outcomes for surgical resection of targetable tumors. This confirmatory study ...
Oliver Zivanovic and Dennis S. Chi, Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA Disclosure: The authors have no ...
A recent study found that certain gene variants may be prognostic for residual disease following resection in patients with ovarian cancer. Whether a patient has residual disease following primary ...
ovarian cancer Study patients who received Avastin plus chemotherapy followed by Avastin alone, had a greater median PFS vs patients who received chemotherapy alone (18.2 months vs 12 months; hazard ...
Neoadjuvant treatment with olaparib (Lynparza) prior to surgical resection and adjuvant chemotherapy was well tolerated and associated with a 100% optimal resection rate in patients with newly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback